Immunic to showcase IMU-856 research at June conferences

Immunic Inc (NASDAQ:IMUX, FRA:10VA) announced participation in several June investor, industry and scientific events. Management will join the H.C. Wainwright Neuro Perspectives Expert Summit on June 15-16, including a fireside chat and investor meetings. The company will also attend the BIO International Convention in San Diego on June 22-25. At the EFMC-ACSMEDI Medicinal Chemistry Frontiers Symposium in Dublin, Immunic will present research on IMU-856. The company’s medical team will also participate in the European Academy of Neurology Congress in Geneva from June 27-30.